These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
162 related items for PubMed ID: 3278814
1. Bacterial cysteine conjugate beta-lyase and the metabolism of cysteine S-conjugates: structural requirements for the cleavage of S-conjugates and the formation of reactive intermediates. Vamvakas S, Berthold K, Dekant W, Henschler D. Chem Biol Interact; 1988; 65(1):59-71. PubMed ID: 3278814 [Abstract] [Full Text] [Related]
11. Roles of cysteine conjugate beta-lyase and S-oxidase in nephrotoxicity: studies with S-(1,2-dichlorovinyl)-L-cysteine and S-(1,2-dichlorovinyl)-L-cysteine sulfoxide. Lash LH, Sausen PJ, Duescher RJ, Cooley AJ, Elfarra AA. J Pharmacol Exp Ther; 1994 Apr 05; 269(1):374-83. PubMed ID: 8169843 [Abstract] [Full Text] [Related]
12. Cysteine conjugate beta-lyase-dependent biotransformation of the cysteine S-conjugates of the sevoflurane degradation product compound A in human, nonhuman primate, and rat kidney cytosol and mitochondria. Iyer RA, Anders MW. Anesthesiology; 1996 Dec 05; 85(6):1454-61. PubMed ID: 8968194 [Abstract] [Full Text] [Related]
13. Cysteine conjugate beta-lyase-dependent biotransformation of the cysteine S-conjugates of the sevoflurane degradation product 2-(fluoromethoxy)-1,1,3,3,3-pentafluoro-1-propene (compound A). Iyer RA, Anders MW. Chem Res Toxicol; 1997 Jul 05; 10(7):811-9. PubMed ID: 9250416 [Abstract] [Full Text] [Related]
14. Bioactivation of S-(2,2-dihalo-1,1-difluoroethyl)-L-cysteines and S-(trihalovinyl)-L-cysteines by cysteine S-conjugate beta-lyase: indications for formation of both thionoacylating species and thiiranes as reactive intermediates. Commandeur JN, King LJ, Koymans L, Vermeulen NP. Chem Res Toxicol; 1996 Jul 05; 9(7):1092-102. PubMed ID: 8902263 [Abstract] [Full Text] [Related]
15. Quantitation of multiple pathways for the metabolism of nephrotoxic cysteine conjugates using selective inhibitors of L-alpha-hydroxy acid oxidase (L-amino acid oxidase) and cysteine conjugate beta-lyase. Stevens JL, Hatzinger PB, Hayden PJ. Drug Metab Dispos; 1989 Jul 05; 17(3):297-303. PubMed ID: 2568912 [Abstract] [Full Text] [Related]
16. Structure-mutagenicity and structure-cytotoxicity studies on bromine-containing cysteine S-conjugates and related compounds. Finkelstein MB, Vamvakas S, Bittner D, Anders MW. Chem Res Toxicol; 1994 Jul 05; 7(2):157-63. PubMed ID: 8199303 [Abstract] [Full Text] [Related]
18. Assessment of unscheduled DNA synthesis in a cultured line of renal epithelial cells exposed to cysteine S-conjugates of haloalkenes and haloalkanes. Vamvakas S, Dekant W, Henschler D. Mutat Res; 1989 Apr 05; 222(4):329-35. PubMed ID: 2704384 [Abstract] [Full Text] [Related]
19. Renal cysteine conjugate beta-lyase. Bioactivation of nephrotoxic cysteine S-conjugates in mitochondrial outer membrane. Lash LH, Elfarra AA, Anders MW. J Biol Chem; 1986 May 05; 261(13):5930-5. PubMed ID: 3700378 [Abstract] [Full Text] [Related]
20. Thioacylating agents as ultimate intermediates in the beta-lyase catalysed metabolism of S-(pentachloro-butadienyl)-L-cysteine. Dekant W, Berthold K, Vamvakas S, Henschler D. Chem Biol Interact; 1988 May 05; 67(1-2):139-48. PubMed ID: 3168080 [Abstract] [Full Text] [Related] Page: [Next] [New Search]